Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immune Pharmaceuticals Inc (IMNP)

Immune Pharmaceuticals Inc (IMNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 158
  • Shares Outstanding, K 49,313
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,890 K
  • 60-Month Beta 3.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.17
Trade IMNP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.86
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 04/01/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -3.40
  • Growth Rate Est. (year over year) +29,482.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0023 +39.13%
on 02/19/19
0.0123 -73.98%
on 01/31/19
-0.0048 (-60.00%)
since 01/18/19
3-Month
0.0023 +39.13%
on 02/19/19
0.0490 -93.47%
on 11/27/18
-0.0343 (-91.47%)
since 11/19/18
52-Week
0.0023 +39.13%
on 02/19/19
0.4750 -99.33%
on 02/20/18
-0.4868 (-99.35%)
since 02/16/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune's lead program, bertilimumab, is a first-in-class, human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.0063
1st Resistance Point 0.0048
Last Price 0.0032
1st Support Level 0.0020
2nd Support Level 0.0007
3rd Support Level N/A

See More

52-Week High 0.4750
Fibonacci 61.8% 0.2944
Fibonacci 50% 0.2386
Fibonacci 38.2% 0.1829
Last Price 0.0032
52-Week Low 0.0023

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar